Topic: Pharmaceuticals Sector

The Myelin Repair Foundation Encourages Collaboration for a Cure

Scientists in their labs. Big Pharma in pursuit of the next blockbuster. An innovative foundation brings them together to speed up the discovery of multiple-sclerosis drugs.READ»

Telemedicine Gets a Boost From Novartis and the Earth Institute

The Bonsaaso Millennium Village to be crowned with telemedicine upgrades.READ»

A Disease-Fighting UN Backed by Big Pharma

A representative of big pharma calls for a UN-like compact to fight antibiotic resistance diseases in the developing world.READ»

Where Are Drug Company Profits Really Going?

The leading trade organization for U.S. drug companies, Pharmaceutical Research and Manufacturers of America, or PhRMA, keeps telling American consumers that the high cost of drugs is due to pricey research and development costs, but ...READ»

PhRMA Chokes International Trade

The Pharmaceutical Research and Manufacturers of America (PhRMA), the leading trade organization for U.S. drug companies, does not want U.S. consumers to have a choice of where they buy their drugs. To keep U.S. consumers from researching foreign markets to find safe drugs at prices as much as three or four times less than in the United States, PhRMA and its members started aggressively shutting down the drug supply to international pharmacies, disabling them from dispensing to U.S. citizens.READ»

Prescription Drug Stats a Bitter Pill to Swallow

Americans are loading up an anti-anxiety drugs -- and lining the pockets of Big Pharma.READ»

Use Your Business’ Reach For Financial Gain

PDI expands its self conception.READ»

Project GreenVax Makes Vaccines Out of Tobacco Plants Instead of Eggs

Did you get a H1N1 flu shot? You can thank unhatched chicken eggs for that. But a new venture dubbed Project GreenVax aims to take animals completely out of the equation by making vaccines with tobacco plants. In traditional ...READ»

Most Innovative Companies - Biotech

Sponsored by by Elizabeth ...READ»

ENERGY AND PHARMACEUTICAL ENZYMES CODEXIS IPO

CODEXIS filed a $100 million initial public offering (IPO). CODEXIS based in the United States is a joint partnership of industry leading biotechnology and energy companies such as Bio One Capital, DYADIC INTERNATIONAL, General Electric Energy, Maxygen, Pfizer, Royal Dutch/Shell, Chevron Biofuels, CMEA Capital, and FirstMark Capital. The IPO was underwritten by investment banking leaders Credit Suisse and Goldman Sachs. READ»

Side Effects with Side Effects

Each day we open the paper or turn on the computer and there is another story about an FDA approved drug that causes serious injuries or death. READ»

Paxil Once Again Stalks Potential Victims

The safety of drugs these days is a major issue not only with patients, but in the legal arena as med mal attorneys fight for justice for victims. READ»

Are Your Interns Saving the World? IBM's Are

Let's play word association: intern + texting = ____. Setting up a date? Skipping out on work? Sexting? At IBM, how about saving millions of lives? A new initiative called SMS for Life, born from the minds of a group of IBM's Extreme ...READ»

Health Insurance Quotes Reform Weeklys EasyToInsureME

This week Senate lawmakers continued to debate numerous proposed amendments to Senate Majority Leader Harry Reid's (D-NV) health care reform bill.READ»

Vaccine Technology Conference

The 1950s and 1960s were momentous for drug manufacturers, which introduced vaccines for polio, measles, mumps, and a host of other diseases. Over time, though, many pharmaceutical companies deemphasized vaccines in favor of ...READ»

Lost Dollars in Gene Research

Billions of R&D dollars flowed to companies promising to cure our ills. Most of those companies are now dead or forgotten.READ»

• The Gene Bubble

Traditional Chasm Market Segmentation - Moving to the Max Segmentation Strategy

 Whole books have been written about market segmentation, so it is difficult to summarize it on a page. One of the leading segmentation methodologies, that became part of teaching at the Harvard Business School, is what we lived ...READ»

Why Vaccine Makers Can't Keep Up with the H1N1 Virus

There isn't enough H1N1 vaccine to go around, which is why President Barack Obama declared the outbreak a national emergency over the weekend. Why can't we produce H1N1 vaccines fast enough? Because of chicken eggs.READ»

$5M to Make NYC a Hub for Biotech Startups

San Francisco, Los Angeles, and San Diego are often referred to as the major U.S. biotech hubs. New York City, no longer content to remain king of media and finance, is determined to join the club. To that end, the NYCIF, Henry ...READ»

Can Protein Sciences Produce a Swine Flu Vaccine in Time? Update: Likely No

As the start of a new school year begins, concerns over H1N1--aka swine flu--are growing. Everyone's waiting to hear when a vaccine will be available, and earlier this summer, the CDC predicted that 120 million doses ... READ»

Defective Drugs Take Their Toll

Anyone who has been made sick by taking a drug with ghastly side effects knows full well they can take their deadly toll. READ»

Reduced Prescription Costs for Seniors Soon a Reality

The good news for seniors in America is that pharmaceutical companies have agreed to cut the prices of prescription drugs for seniors.READ»

Blowing the Whistle for the IRS

Most people would just love to get money from the IRS, and not just their regular tax refund, but instead a major chunk of change that would set them up for life.READ»

Did Merck Really Try to Deliberately Silence Critics?

Disturbing article on Total Health Breakthroughs about a deliberate campaign by Merck to intimidate, defund ,and otherwise make life miserable for doctors who dared to speak out about the nasty and sometimes-lethal side effects of ...READ»

Drug Companies Love Profits

It's not too surprising that drug companies love profit and focus on staying in business by creating and marketing new drugs. READ»